Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Approvals/Philippines FDA/Klarithro

Approved

STANDARD

Klarithro

Fredun Pharmaceuticals Limited🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: 865e81ac41b77209
Company: Fredun Pharmaceuticals Limited
Type: Standard

Approval Details

Approval Id: 865e81ac41b77209
Drug Approval Philippines Name: Klarithro
Product Name: Klarithro
Registration Number: DRP-14518
Brand Name: Klarithro
Generic Name: Clarithromycin
Dosage Form: Film-Coated Tablets
Dosage Strength: 500mg
Manufacturer: Fredun Pharmaceuticals Limited
Importer: Amb Hk Enterprises Inc.
Distributor: Amb Hk Enterprises Inc.
Issuance Date: 28 September 2023
Expiry Date: 28 September 2028
Classification: Prescription Drug (RX)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

865e81ac41b77209

Type

Standard

Back to Philippines FDA Approvals

Klarithro - Philippines FDA Drug Approval Details